27 Jun Concordia could be an inversion target; MiRagen re-ups with Servier; …read more Source: Concordia could be an inversion target; MiRagen re-ups with Servier; 0 No comments admin blog Soon-Shiong: Investors should be patient with biotech After multiple studies, MannKind finally wins an FDA OK for inhaled insulin Afrezza
